A Luminex assay detects amyloid β oligomers in Alzheimer's disease cerebrospinal fluid.
Amyloid beta (aβ) protein assembles into larger protein aggregates during the pathogenesis of Alzheimer's disease (AD) and there is increasing evidence that soluble aβ oligomers are a critical pathologic species. Diagnostic evaluations rely on the measurement of increased tau and decreased aβ42...
Saved in:
Main Authors: | Adrianna Z Herskovits, Joseph J Locascio, Elaine R Peskind, Ge Li, Bradley T Hyman |
---|---|
Format: | article |
Language: | EN |
Published: |
Public Library of Science (PLoS)
2013
|
Subjects: | |
Online Access: | https://doaj.org/article/c11db52ec3a644b586af0be0eb70ffb0 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Identification and validation of novel cerebrospinal fluid biomarkers for staging early Alzheimer's disease.
by: Richard J Perrin, et al.
Published: (2011) -
C-terminal fragments of the amyloid precursor protein in cerebrospinal fluid as potential biomarkers for Alzheimer disease
by: María-Salud García-Ayllón, et al.
Published: (2017) -
Low cerebrospinal fluid Amyloid-βeta 1–42 in patients with tuberculous meningitis
by: Giacomo Stroffolini, et al.
Published: (2021) -
Correction to: Cerebrospinal fluid levels of the neurotrophic factor neuroleukin are increased in early Alzheimer’s disease, but not in cerebral amyloid angiopathy
by: Anna M. De Kort, et al.
Published: (2021) -
Mitochondrial ubiquitin ligase alleviates Alzheimer’s disease pathology via blocking the toxic amyloid-β oligomer generation
by: Keisuke Takeda, et al.
Published: (2021)